EP3022192
Píperídínýlindólafleiður og notkun þeirra sem hemlar magnaþáttar B
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.7.2014EP published:
11.10.2017EP application number:
14744744.5
EP translation filed:
29.11.2017Grant published:
15.12.2017EPO information:
European Patent Register
Max expiry date:
13.7.2034Expiry date:
13.7.2026Next due date:
31.7.2026
Title:
PIPERIDINYL INDOLE DERIVATIVES AND THEIR USE AS COMPLEMENT FACTOR B INHIBITORS
Timeline
Today
14.7.2014EP application
11.10.2017EP Publication
29.11.2017Translation submitted
15.12.2017Registration published
13.7.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
ADAMS, ChristopherAddress:
Cambridge, MA, US
Name:
CAPPARELLI, Michael PaulAddress:
Cambridge, MA, US
Name:
EHARA, TakeruAddress:
Cambridge, MA, US
Name:
KARKI, Rajeshri GaneshAddress:
Cambridge, MA, US
Name:
MAINOLFI, NelloAddress:
Belmont, MA, US
Name:
ZHANG, ChunAddress:
Cambridge, MA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361846355 PDate:
15.7.2013Country:
US
Number:
201461977028 PDate:
8.4.2014Country:
US
Supplementary protection
SPC number:
SPC482
Classification
Categories:
C07D 401/14, C07D 413/14, C07D 401/06, C07D 403/06, C07D 417/14, A61K 31/454, A61K 31/4545, A61K 31/5377, A61P 27/00, A61P 37/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 27.6.2018
Expires: 13.7.2019
Payer: Árnason Faktor
Number: 6
Paid: 25.6.2019
Expires: 13.7.2020
Payer: Árnason Faktor
Number: 7
Paid: 25.6.2020
Expires: 13.7.2021
Payer: Árnason Faktor ehf.
Number: 8
Paid: 24.6.2021
Expires: 13.7.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 29.6.2022
Expires: 13.7.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 28.6.2023
Expires: 13.7.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 24.6.2024
Expires: 13.7.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 18.7.2025
Expires: 13.7.2026
Payer: Árnason Faktor ehf.